|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01415596 |
|
Date of registration:
|
11/08/2011 |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of High Dose Salbutamol on Muscle Performance
|
|
Scientific title:
|
The Effect of High Dose Salbutamol on Dynamic and Isometric Muscle Power and Recovery in Well-trained Males |
|
Date of first enrolment:
|
August 2011 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01415596 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Males
- age 18-45
- training frequency > 10 hrs/wk
- informed consent
Exclusion Criteria:
- smoker or former smoker
- chronic diseases, as well as asthma
- allergy to the study drugs
- intake of any form of medicin or inhibited drugs during the study
- use of beta2-agonist 14 days before the intervention
Age minimum:
18 Years
Age maximum:
45 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Ergogenic Effects of Salbutamol in Healthy Males
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: salbutamol
|
|
Primary Outcome(s)
|
|
Muscle power
|
|
Secondary Outcome(s)
|
|
Muscle recovery
|
|
Secondary ID(s)
|
|
SALMUS2011
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|